Inversion Therapeutics

Burlingame, CA · Founded 2025 · Privately Held (backing)

Developer of an oncology biotech platform designed to discover and progress therapies against previously untapped cancer mechanisms. Inversion Therapeutics is based in Burlingame, CA and was founded in 2025. It was valued at $17 million at its seed round in Aug 2025, the last priced event on record. It has raised $6.9 million across 1 recorded round; the latest was a $6.9 million early-stage round in Jun 2025.

PMV mark · valuation
$17.0M
Oct 2026
Priced at
its seed round
Aug 2025
Total raised
$6.9M
Last round
Early Stage VC
Jun 2025
How much has Inversion Therapeutics raised?
$6.9Macross 1 recorded rounds · Jun 2025 – Jun 2025

Most recently, Inversion Therapeutics raised $6.9M in its Early Stage VC (Jun 2025).

Free account
More of Inversion Therapeutics with a free account
  • ·Watch Inversion Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Inversion Therapeutics round by round

1 rounds
Jun 2025Early Stage VC$6.9MSEC filing▮
4 investors participated

How much has Inversion Therapeutics raised?

Inversion Therapeutics has raised $6.9 million across 1 recorded round since 2025. The largest was a $6.9 million early-stage round in Jun 2025.

Inversion Therapeutics has filed 1 Form D with the SEC, most recently in Aug 2025 ($6.9 million sold to 4 investors).

Inversion Therapeutics investors

1 investor is on record for Inversion Therapeutics, including Red Tree Venture Capital. By type, the record holds 1 venture capital firm. The early-stage round in Jun 2025 drew 4 investors.

For fundraisers
Raising for a company like Inversion Therapeutics?

1 investors have backed Inversion Therapeutics.

See all 1 investors →

Frequently asked about Inversion Therapeutics

How much has Inversion Therapeutics raised?
Inversion Therapeutics has raised $6.9M in total across 1 recorded funding rounds.
When was Inversion Therapeutics's last funding round?
Inversion Therapeutics's most recent recorded round was Early Stage VC in Jun 2025, raising $6.9M.